Palomar Medical (PMTI) Approves 1.5M Common Buyback Plan
Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a global leader in laser and other light-based systems for aesthetic treatments, today announced its Board of Directors has approved a Stock Repurchase Program under which the Company is authorized to repurchase up to one million five hundred thousand shares of its common stock. This program is authorized to begin immediately. Any stock repurchases will be made from time to time through open market purchases, block purchases and other transactions complying with the Securities and Exchange Commission's Rule 10b-18. The timing and actual number of shares purchased will depend on a variety of factors such as price, corporate and regulatory requirements, alternative investment opportunities and other market conditions. Stock repurchases under this program, if any, will be made using the Company's cash resources, and may be commenced or suspended at any time or from time to time at management's discretion without prior notice.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SoulCycle Files for $100M Common Stock IPO
- Citrix Systems (CTXS), Elliott Management Enter Cooperation Agreement
- SEC said to complete CEO pay ratio rule - WSJ
Create E-mail Alert Related CategoriesStock Buybacks
Related EntitiesStock Buyback
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!